Beckman Laser Institute Korea, Dankook University, 119 Dandae-ro, Cheonan, Chungnam, 330-714, South Korea.
Lasers Med Sci. 2015 Feb;30(2):533-41. doi: 10.1007/s10103-014-1699-9. Epub 2015 Jan 8.
The objective of this study was to investigate the effects on the vascular regeneration of adipose-derived stem cells (ASCs) by using red light-emitting diode (LED) irradiation in ischemic hind limbs. Low-level light therapy (LLLT) has been shown to enhance proliferation and cytokine secretion of a number of cells. ASCs are an attractive cell source for vascular tissue engineering. This approach is hindered because transplanted ASCs decline rapidly in the recipient tissue. Ischemic hind limbs were treated with LLLT from an LED array (660 nm) at an irradiance of 50 mW/cm(2) and a radiant exposure of 30 J/cm(2). LLLT, ASC transplantation, and ASC transplantation with LLLT (ASC + LLLT) were applied to ischemic limbs, and cell survival and differentiation, and secretion of vascular endothelial growth factor and basic fibroblast growth factor of the ASCs were evaluated by immunostaining and Western blot analyses. Vascular regeneration was assessed by immunostaining and hematoxylin and eosin staining. In the ASC + LLLT group, the survival of ASCs was increased due to the decreased apoptosis of ASCs. The secretion of growth factors was stimulated in this group compared with ASCs alone. The ASC + LLLT group displayed improved treatment efficacy including neovascularization and tissue regeneration compared with ASCs alone. In particular, quantitative analysis of laser Doppler blood perfusion image ratio showed that blood perfusion was enhanced significantly (p < 0.05) by ASC + LLLT treatment. These data suggest that LLLT is an effective biostimulator of ASCs in vascular regeneration, which enhances the survival of ASCs and stimulates the secretion of growth factors in ischemic limbs.
本研究旨在探讨应用红光发光二极管(LED)照射缺血后肢对脂肪来源干细胞(ASCs)血管再生的影响。低水平光疗(LLLT)已被证明能增强多种细胞的增殖和细胞因子分泌。ASCs 是血管组织工程中一种有吸引力的细胞来源。这种方法受到阻碍,因为移植的 ASCs 在受者组织中迅速减少。缺血后肢用 LED 阵列(660nm)以 50mW/cm2 的辐照度和 30J/cm2 的辐射暴露进行 LLLT 治疗。LLLT、ASC 移植和 ASC 移植联合 LLLT(ASC+LLLT)应用于缺血肢体,并通过免疫染色和 Western blot 分析评估 ASCs 的细胞存活和分化以及血管内皮生长因子和碱性成纤维细胞生长因子的分泌。通过免疫染色和苏木精和伊红染色评估血管再生。在 ASC+LLLT 组中,由于 ASCs 凋亡减少,ASCs 的存活率增加。与单独的 ASCs 相比,该组生长因子的分泌受到刺激。与单独的 ASCs 相比,ASC+LLLT 组显示出改善的治疗效果,包括新生血管形成和组织再生。特别是,激光多普勒血流灌注图像比的定量分析显示,ASC+LLLT 治疗显著增强了(p<0.05)血流灌注。这些数据表明,LLLT 是血管再生中 ASCs 的有效生物刺激物,它增强了 ASCs 的存活并刺激了缺血肢体中生长因子的分泌。